Andere Sprachen Evaxion Biotech A/S

Aktien

A400P5

US29970R2040

EVAX

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 05.12.2024			% 5 Tage	% 1. Jan.
1,380 ^USD	-3,50 %		-12,10 %	-79,87 %

05.12.	Europäische Aktien, die in den USA als American Depositary gehandelt werden, steigen im Donnerstagshandel	MT
04.12.	Europäische Aktien werden in den USA als American Depositary Receipts gehandelt, die im Mittwochshandel leicht steigen	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Rise in Thursday Trading	05.12.
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading	04.12.
Evaxion Biotech A/S : to present preclinical Proof of Concept for precision ERV cancer vaccine concept at ESMO Immuno Oncology Congress Form 6 K	03.12.
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading	02.12.
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress	02.12.
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading	27.11.
European Equities Traded in the US as American Depositary Rise in Monday Trading	18.11.
European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week	15.11.
European Equities Traded in the US as American Depositary Fall in Wednesday Trading	13.11.
Evaxion Biotech A/S : receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing Form 6 K	13.11.
Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing	13.11.
Evaxion Biotech A/S : announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX V1 Form 6 K	13.11.
European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading	12.11.
ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I002	12.11.
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1	12.11.
ExpreS2ion Biotechnologies ApS Announces Positive New Preclinical Data from its Ongoing Cytomegalovirus Vaccine Program Collaboration with Evaxion Biotech A/S, Names ES2B-I002	12.11.
Evaxion Announces Positive Preclinical Data for Cytomegalovirus Vaccine Program EVX-V1	12.11.
European Equities Traded in the US as American Depositary Move Higher in Monday Trading	11.11.
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday	01.11.
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading	31.10.
Evaxion Biotech A/S : announces business update and third quarter 2024 financial results Form 6 K	31.10.
Earnings Flash (EVAX) EVAXION BIOTECH Posts Q3 Revenue $3M	31.10.
Evaxion announces business update and third quarter 2024 financial results	31.10.
Evaxion Biotech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	31.10.
Evaxion Biotech A/S : to announce business update and third quarter 2024 financial results on October 31 Form 6 K	28.10.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evaxion Biotech A/S

Aktien

A400P5

US29970R2040

EVAX

Biotechnologie

Andere Sprachen

Filter